本科教学
科研动态
 
学生工作
招生工作
 
科技服务
司法鉴定
 
实验动物服务
设备共享平台

 
  学校首页   学校通知
  学校发文   网关登录
  下载专区   VPN
 
 
> 首页 > 学术活动

药学院学术报告[2017年4月7日14:00]

【日期:2017-4-5 10:50:16】 【人气:102】  【关 闭】  【打 印

报告题目:Targeting sphingolipid signalling for stroke

报 告 人:Christian Waeber, Senior Lecturer in Pharmacology (School of Pharmacy, University College Cork, Ireland)

报告时间:2017年4月7日(周五) 14:00

报告地点:独墅湖校区二期云轩楼2301室


Dr. Christian Waebe简介


Christian Waeber received his master’s degree in biochemistry from the University of Fribourg (Switzerland) and then worked as a Ph.D. student at Novartis Basel, where he characterized the pharmacological profile, signalling pathways and brain distribution of 5-HT1D receptors. He was awarded a Ph.D. in biochemistry in 1991 by the University of Fribourg. After a first post-doctoral fellowship in the laboratory of Joel Bockaert at the “CNRS-INSERM Center for Pharmacology and Endocrinology” in Montpellier (France), DrWaeber moved in 1993 to Harvard Medical School to characterize the pharmacological profile of 5-HT receptors mediating the effects of antimigraine drugs. Fifteen years ago, DrWaeber switched topics, largely abandoning research on 5-HT to focus on the role of sphingosine-1-phosphate receptors in blood vessels and brain. His research was instrumental in demonstrating the therapeutic potential of the S1P agonist and Multiple Sclerosis drug fingolimod for the acute treatment of stroke. After 20 years in Boston, DrWaeber joined School of Pharmacy,University College Cork (Ireland) in 2013. DrWaeber’s 120+ original publicationshave been cited more than 16000 times.


(药学院)

关闭页面】【页面顶部

Copyright (c) 苏州大学医学部 2009, All Rights Reserved

地址:苏州工业园区仁爱路199号 邮编:215123 电话:0512-65884028 主任信箱:sdyxb@suda.edu.cn